This webcast will help clinicians develop a refined understanding of residual CVD risk in hypercholesterolemic patients and allow them to adjust prescribing behavior to reduce risk as much as possible.

This program features slides and a transcription of the speakers’ presentations from a live meeting held on October 30, 2017. Internationally renowned experts discuss the clinical issues and recent data regarding antiplatelet/anticoagulation in patients with coronary artery disease (CAD).